• Goldenwell Biotech filed Form NT 10-Q, flagging a delay in its quarterly report for period ended March 31, 2026.
• Delay tied to inability to compile all information for financial statements and related disclosures without unreasonable effort or expense.
• 10-Q expected to be filed on or before May 19, 2026.
• Filing also disclosed annual report on Form 10-K for fiscal year ended March 31, 2026 has not been filed.
• Notice indicated no anticipated significant change in results of operations versus prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Goldenwell Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-002962), on May 12, 2026, and is solely responsible for the information contained therein.